Table 3

Mean symptom, sign and total scores (SD) of 100 patients with meibomian gland dysfunction at four clinical visits

Azithromycin group (50 patients)Doxycycline group (50 patients)p Value95% CI
Pretreatment
 Symptom7.2 (2.3)6.8 (2)0.3−0.4 to 1.2
 Sign10.6 (2.7)11.3 (2.2)0.1−1.7 to 0.2
 Total17.8 (4.5)18.2 (3.8)0.6−2 to 1.2
First follow-up
 Symptom5.5 (2.2)5.7 (2)0.6−1 to 0.6
 Sign7.9 (2.8)8.5 (2.4)0.2−1.7 to 0.3
 Total13.4 (4.5)14.2 (4)0.3−2.5 to 0.8
Second follow-up
 Symptom4.8 (2.1)5 (1.7)0.6−0.9 to 0.5
 Sign6.4 (2.6)7.6 (2.3)0.01−2.2 to −0.2
 Total11.3 (4)12.9 (3.2)0.02−3 to −0.1
Last follow-up
 Symptom4.3 (2.2)5 (2.1)0.1−1.5 to 0.2
 Sign4.8 (2.5)6.7 (2.5)<0.001−2.8 to −0.8
 Total9.1 (4.1)11.7 (4)0.002−4.2 to −0.9
  • Lower scores show less severity.